Avoid common mistakes on your manuscript.
Severe SARS-CoV-2 infection is associated with a high incidence of acute kidney injury (AKI), ranging in different studies between 4.5% [1] and 28% [2], with a higher prevalence in patients hospitalized in the intensive care unit (ICU) [1, 2]. In addition, among patients with coronavirus disease 2019 (COVID-19) hospitalized in the ICU, AKI was an independent risk factor for mortality [3].
Along with AKI, other laboratory patterns of kidney damage, such as the presence of isolated urinary abnormalities like proteinuria and haematuria, have been described in patients affected by COVID-19, albeit less frequently [4].
Although several mechanisms have been proposed to explain the pathogenesis of COVID-19–associated AKI [4,5,6], a better understanding of kidney pathology findings in COVID-19 still represents an unmet need, and reports of autopsy studies are very limited in the literature.
In this single-centre retrospective study, we examined the kidney samples of 43 patients with a severe form of COVID-19 who died in the ICU of the Ospedale Luigi Sacco, Milan, Italy, during the first COVID-19 wave of 2020. The total number of ICU admissions during the enrolment period was 101, and 43 of the 54 patients who died underwent autopsy.
Biopsies were performed on both kidneys shortly after death, following which, tissues were fixed in 10% buffered formalin at room temperature for up to 48 h, and histopathological examination was performed using tissue sections stained with periodic acid-Schiff, acid fuchsin orange trichrome, silver stain, and hematoxylin–eosin. The extent of glomerular and tubular damage was classified according to the score described in Table 1.
To assess tubular damage, we also considered the presence of endoluminal casts and the erosion of the tubular epithelium. Finally, to grade the glomerular damage we evaluated the general appearance of the glomerular flocculus.
In addition to histopathological examination, molecular biology analysis for the detection of SARS-CoV-2 was performed on the renal tissues of 20 patients (46%).
RNA was extracted from 5 μm thick paraffin-embedded sections using Quick- RNA FFPE Miniprep (Zymo Research). Two SARS-CoV-2 target genes were then amplified and tested in all patients: (i) RNA-dependent RNA polymerase gene (RdRP gene, Co-Diagnostic, Salk Lake City, Utah, USA), (ii) envelope (E gene, the WHO/Charité, Berlin, Germany).
The mean age of the examined population was 63.2 years (range min–max 34–80, SD±9.1), and 93.0% of the patients were male. Mean hospitalization time was 12.5 days (SD ±9.7).
AKI was frequent in our population, affecting 24 patients (55.8%). Eleven of the patients with AKI (47.8%) needed continuous renal replacement therapy. As in other forms of acute respiratory distress syndrome, patients with COVID-19 acute respiratory distress syndrome underwent numerous cycles of position change from supine to prone, according to their arterial blood gases evaluated by pO2/FIO2 ratio. Fifteen (65%) patients underwent position change from supine to prone whereas 15 (65%) underwent prone-supination at least once in the 72 h before death. All patients required invasive ventilation, with administration of different levels of Positive End Expiratory Pressure (PEEP). The mean PEEP value administered in the first 7 days of admission to the ICU was 13.77 cmH2O (range min–max 4.85–18, SD±3.11).
We identified several patterns of histopathological changes in the renal parenchyma. The tubules showed severe alteration of the epithelium, with denudation of the basement membrane, loss of the brush border, and eventually increased cellular mitosis. Moreover, we identified the presence of casts within the lumen of the tubules, with a rigid, stiff, and dichromic appearance.
On the other hand, glomerular damage consisted mainly of the collapse of the glomerular tuft on the vascular pole (Fig. 1). Of note, none of the examined cases showed sclerosis of the mesangium, or necrosis and inflammatory changes, and neither the interstitium nor the glomerulus showed significant inflammatory infiltrate. Indeed, no lympho-monocytic inflammatory infiltrate or vascular and thrombotic lesions were observed in any of the cases.
In our population, 55.8% of patients (24/43) had mild tubular damage, 39.5% (17/43) had moderate tubular damage, and 4.65% (2/43) had severe tubular damage (Fig. 2A).
Glomerular damage was more severe, with 39.5% of patients (17/43) having mild glomerular damage, 37.2% (16/43) with moderate glomerular damage, and 23.2% (10/43) with severe glomerular damage (Fig. 2B). Comparison between the different degrees of glomerular and tubular damage revealed no differences related to the age of the patients (Table 2).
Molecular evaluation for the identification of the SARS- CoV-2 genome on the kidney tissues by polymerase chain reaction was positive in only 4/20 cases (20%), equally distributed between the AKI group and the non-AKI group.
Acute tubular damage is the main risk factor leading to AKI. In our study, moderate and severe tubular damage was present in 19 patients and correlated with AKI [OR = 54 (95% CI 5.9–495.0) p = 0.0004]. However, our study also revealed the presence of severe glomerular damage. Indeed, collapsing glomerulopathy was detected in a high percentage of patients (26/43–60.4%) and significantly correlated with the presence of AKI [OR 6.5 (95% CI 1.7–25.3); p = 0.007].
Collapsing glomerulopathy is not a typical pattern described for AKI. In addition, the morphological appearance of the glomerular damage was consistent with new-onset ischaemic damage, suggesting that the glomerular damage might be the consequence of the ischaemic insult itself.
Interestingly, no signs of direct viral damage, such as interstitial inflammatory infiltrate were detected.
Based on the observation of non-specific histological findings, we hypothesise that kidney abnormalities might be the consequence of multifactorial damage, mainly produced by the ischaemic injury. In addition, we previously documented a significant correlation between PEEP levels and AKI in COVID-19 patients, which could contribute to develo** this peculiar type of kidney damage [7].
However, despite the observed severe tubular and glomerular injury, the absence of sclerosis suggests potentially reversible ischaemic damage. Kidney biopsies from patients who experienced COVID-19-related AKI and eventually recovered would help understand the long-term kidney outcome.
Data availability
All data generated or analysed during this study are included in this published article.
References
Yang X, ** Y, Li R, Zhang Z, Sun R, Chen D (2020) Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care 24(1):1–8. https://doi.org/10.1186/s13054-020-03065-4
Silver SA, Beaubien-Souligny W, Shah PS et al (2021) The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis. Kidney Med 3(1):83-98.e1. https://doi.org/10.1016/j.xkme.2020.11.008
Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829–838. https://doi.org/10.1016/j.kint.2020.03.005
Nadim MK, Forni LG, Mehta RL et al (2020) COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 16(12):747–764. https://doi.org/10.1038/s41581-020-00356-5
Legrand M, Bell S, Forni L et al (2021) Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 17(11):751–764. https://doi.org/10.1038/s41581-021-00452-0
Ng JH, Bijol V, Sparks MA, Sise ME, Izzedine H, Jhaveri KD (2020) Pathophysiology and pathology of acute kidney injury in patients with COVID-19. Adv Chronic Kidney Dis 27(5):365–376. https://doi.org/10.1053/j.ackd.2020.09.003
Ottolina D, Zazzeron L, Trevisi L et al (2022) Acute kidney injury (AKI) in patients with Covid-19 infection is associated with ventilatory management with elevated positive end-expiratory pressure (PEEP). J Nephrol 35(1):99–111. https://doi.org/10.1007/s40620-021-01100-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no conflict of interest to disclose.
Ethical statement
The study was conducted in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later amendments. The study was approved by the local ethics committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Perego, A.A.M., Sabiu, G., Ottolina, D. et al. Post-mortem renal histopathological findings in 43 COVID-19 patients with acute kidney injury (AKI) deceased in the intensive care unit. J Nephrol 36, 605–608 (2023). https://doi.org/10.1007/s40620-023-01587-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-023-01587-y